Zynerba Pharmaceuticals Receives New U.S. Patent for Treatment of Fragile X Syndrome with Transdermal Cannabidiol
This new patent, which expires in 2038, is part of an expanding intellectual property portfolio.
Read More
Category: US Stocks
CV Sciences, Inc. Announces New Distribution Partnership With Southeastern Grocers
New Partnership with Southeastern Grocers Launches PlusCBD™ Oil Topical Products and Dietary Supplements at 115 Winn-Dixie Stores in Florida and 37 BI-LO Stores in South Carolina.
Read More
Corbus Pharmaceuticals Updates Data from Lenabasum Open-Label Extension Studies in Systemic Sclerosis and Dermatomyositis at 2019 ACR Annual Meeting
Median ACR CRISS score remains 0.95 at 25 months in systemic sclerosis OLE.
Read More
Cara Therapeutics Announces Publication of Difelikefalin (KORSUVA™ Injection) KALM™-1 Phase 3 Trial Results in the New England Journal of Medicine
51.9% of patients in the difelikefalin group achieved the pre-specified primary outcome.
Read More
Abattis Provides Update on Trading Halt and Corporate Developments
Abattis Bioceuticals Corp.’s acquisition of Pro Natura BV has been a great success as revenues have increased significantly since the acquisition.
Read MoreGET LISTED
